Quick Answer
LISATA THERAPEUTICS, INC. reported Stockholders Equity of $14.86 million for the year ending 2025.
- LISATA THERAPEUTICS, INC. showed a decrease of -49.8% in Stockholders Equity from 2024 to 2025.
- This data is from LISATA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $62.51 million | Q3 2011: $73.56 million | Q1 2012: $63.37 million | Q2 2012: $46.35 million | Q3 2012: $48.21 million | Q1 2013: $29.42 million | Q2 2013: $33.46 million | Q3 2013: $35.70 million | Q1 2014: $59.64 million | Q2 2014: $78.04 million | Q3 2014: $63.00 million | Q1 2015: $50.40 million | Q2 2015: $66.38 million | Q3 2015: $55.43 million | Q1 2016: $13.66 million | Q2 2016: $6.05 million | Q3 2016: $10.75 million | Q1 2017: -$791.0 thousand | Q2 2017: $54.42 million | Q3 2017: $53.33 million | Q1 2018: $45.59 million | Q2 2018: $43.74 million | Q3 2018: $41.08 million | Q1 2019: $34.73 million | Q2 2019: $29.89 million | Q3 2019: $25.25 million | Q1 2020: $17.24 million | Q2 2020: $33.81 million | Q3 2020: $37.74 million | Q1 2021: $110.27 million | Q2 2021: $104.93 million | Q3 2021: $98.67 million | Q1 2022: $88.50 million | Q2 2022: $82.39 million | Q3 2022: $72.03 million | Q1 2023: $60.96 million | Q2 2023: $57.97 million | Q3 2023: $52.96 million | Q1 2024: $43.00 million | Q2 2024: $38.25 million | Q3 2024: $33.69 million | Q1 2025: $25.36 million | Q2 2025: $21.03 million | Q3 2025: $17.37 million.
- Over the full 16 years of available data (2010 to 2025), LISATA THERAPEUTICS, INC.'s Stockholders Equity has declined by 69.5%.
- Historical annual values: Fiscal year 2025: $14.86 million | Fiscal year 2024: $29.57 million | Fiscal year 2023: $48.15 million | Fiscal year 2022: $66.58 million | Fiscal year 2021: $92.25 million | Fiscal year 2020: $32.50 million | Fiscal year 2019: $20.82 million | Fiscal year 2018: $37.73 million | Fiscal year 2017: $50.51 million | Fiscal year 2016: $4.88 million | Fiscal year 2015: $23.71 million | Fiscal year 2014: $58.51 million | Fiscal year 2013: $62.54 million | Fiscal year 2012: $33.18 million | Fiscal year 2011: $62.03 million | Fiscal year 2010: $48.66 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: